Peptide Research Collection Library
Explore the compound
Quick Facts
Mechanism of Action
NAD+ is a nicotinamide adenine dinucleotide coenzyme central to cellular redox reactions and is also used as a substrate by enzymes involved in metabolic signaling and DNA-repair pathways.
- Supports cellular-energy metabolism through NAD-dependent mitochondrial and enzymatic pathways [1].
- Associated with healthy-aging research focused on DNA repair, sirtuins, and metabolic signaling [1].
- Commonly discussed for energy, recovery, and metabolic-support goals based on NAD biology [1].
- NIH-indexed literature links NAD pathways to oxidative stress, inflammation, and age-related cellular function [1].
Research Applications & Context
Additional 5 source-reported week-by-week rows are preserved as dry-vial reference records; they have not been established for liquid variants.
Research Dosage Information
Reported research quantities and their source context. These are not recommendations, and source status varies.
Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.
| Phase | Reported Amount | Frequency | Draw Units | Cycle | Notes | Calculator |
|---|---|---|---|---|---|---|
| Reported dose | 250-500 mg IV; 250-1,000 mg precursor oral (not equivalent molecules) | Twice daily (oral precursor trial) | Select a vial | Reported reference only, not a recommendation. not verified in human studies. Route as reported: Oral precursor studied; different from IV NAD+. | ||
| Week 1 | 50 mg | Once daily | Select a vial | 1 week | Community-reported model for 1000 mg dry-vial reference (3 mL reconstitution); not equivalent to pre-mixed liquid. Product-specific applicability not confirmed. | |
| Week 2 | 75 mg | Once daily | Select a vial | 1 week | Community-reported model for 1000 mg dry-vial reference (3 mL reconstitution); not equivalent to pre-mixed liquid. Product-specific applicability not confirmed. | |
| Weeks 3-8 | 100 mg | Once daily | Select a vial | 6 weeks | Community-reported model for 1000 mg dry-vial reference (3 mL reconstitution); not equivalent to pre-mixed liquid. Product-specific applicability not confirmed. | |
| Weeks 9-12 | 100 mg | Once daily | Select a vial | 4 weeks | Community-reported model for 1000 mg dry-vial reference (3 mL reconstitution); not equivalent to pre-mixed liquid. Product-specific applicability not confirmed. | |
| Weeks 13-16 | 100 mg | Once daily | Select a vial | 4 weeks | Community-reported model for 1000 mg dry-vial reference (3 mL reconstitution); not equivalent to pre-mixed liquid. Product-specific applicability not confirmed. |
Dosing Protocol & Schedule
These are mathematical planning summaries derived from reported rows already in the research library. Community-reported schedules are not clinical or validated protocols, recommendations, or directions for human use.
| Include | Phase | Research Dose | Frequency | Weeks | Entries | Total quantity | Volume per entry | U-100 equivalent |
|---|---|---|---|---|---|---|---|---|
| — | Reported dose | 250-500 mg IV; 250-1,000 mg precursor oral (not equivalent molecules) | Twice daily (oral precursor trial) | — | — | A single numeric quantity is needed before planning supplies. | — | — |
| Week 1 | 50 mg | Once daily | 1 | — | — | — | — | |
| Week 2 | 75 mg | Once daily | 1 | — | — | — | — | |
| Weeks 3-8 | 100 mg | Once daily | 6 | — | — | — | — | |
| Weeks 9-12 | 100 mg | Once daily | 4 | — | — | — | — | |
| Weeks 13-16 | 100 mg | Once daily | 4 | — | — | — | — |
Plan a Regimen Schedule
Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.
Reconstitution Calculator
Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.
Reconstitution Reference Chart
Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.
| Example volume | Calculated concentration | Calculator |
|---|---|---|
| 1 mL | — | |
| 2 mL | — | |
| 3 mL | — | |
| 4 mL | — | |
| 5 mL | — |
Choose a compatible dry vial to see reference concentrations.
Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.
Supplies Needed — Estimate
Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.
Select a compatible vial and volume below to view quantities.
Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.
Published References (0 identified)
A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.
Research indexes & other source links
Searches, registries and unverified source records are discovery resources, not verified published studies.
- PubMed.gov biomedical literature: NAD+ View source ↗ PubMed index/search · Source link recorded; claim verification separate
- ClinicalTrials.gov study registry: NAD+ View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
- NIH/NCBI all-databases search: NAD+ View source ↗ NCBI database/search · Source link recorded; claim verification separate
- PubChem / NIH compound record search: NAD+ View source ↗ PubChem database/search · Source link recorded; claim verification separate
